Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Long-Term Investments (2024 - 2025)

PAVmed has reported Long-Term Investments over the past 2 years, most recently at $34.1 million for Q4 2025.

  • Quarterly results put Long-Term Investments at $34.1 million for Q4 2025, up 33.09% from a year ago — trailing twelve months through Dec 2025 was $34.1 million (up 33.09% YoY), and the annual figure for FY2025 was $34.1 million, up 33.09%.
  • Long-Term Investments for Q4 2025 was $34.1 million at PAVmed, up from $31.6 million in the prior quarter.
  • Over the last five years, Long-Term Investments for PAVM hit a ceiling of $46.6 million in Q1 2025 and a floor of $25.6 million in Q4 2024.